ELPRO CEO Frederik Dresen explains how cold chain monitoring moved from compliance to risk management, and what biologics and advanced therapies demand.
Frederik Dresen
Advertisement
Frederik Dresen is Chief executive officer of the ELPRO Group.
Articles by Frederik Dresen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How an FTZ Builds More Flexibility Into Pharmaceutical Inventory Strategy
2
Q&A: Kerem Tokel on Pharma Cargo Theft Hotspots and the Shift to Outbound Diversion
3
Why the Best Drug Launches Are Built to Adapt
4
FAQ: How DOL’s PBM Disclosure Rule Reaches Drugmaker Contracts
5